Axa
SWAV

Axa’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Axa’s Portfolio SWAV Stock Details SWAV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-142,510
Closed -$46.4M – 1151
2024
Q1 		$46.4M Buy
142,510
+136,410
+2,236% +$33.5M 0.14% 155
2023
Q4 		$1.16M Hold
6,100
– – ﹤0.01% 823
2023
Q3 		$1.21M Sell
6,100
-6,100
-50% -$1.44M ﹤0.01% 803
2023
Q2 		$3.48M Sell
12,200
-14,600
-54% -$4.05M 0.01% 628
2023
Q1 		$5.81M Buy
26,800
+11,200
+72% +$2.18M 0.02% 527
2022
Q4 		$3.21M Hold
15,600
– – 0.01% 693
2022
Q3 		$4.34M Buy
15,600
+4,400
+39% +$1.12M 0.02% 604
2022
Q2 		$2.14M Buy
11,200
+7,100
+173% +$1.25M 0.01% 759
2022
Q1 		$850K Buy
+4,100
New +$676K ﹤0.01% 974
2021
Q1 		– Sell
-59,800
Closed -$6.2M – 1360
2020
Q4 		$6.2M Sell
59,800
-52,900
-47% -$4.58M 0.02% 648
2020
Q3 		$8.54M Sell
112,700
-22,700
-17% -$1.29M 0.03% 505
2020
Q2 		$6.41M Buy
135,400
+1,774
+1% +$73.1K 0.03% 543
2020
Q1 		$4.43M Buy
+133,626
New +$5.31M 0.02% 549

Other funds holding SWAV

SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return
UWS
Unique Wealth Strategies Burr Ridge, Illinois $275M AUM 29.58% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $10B AUM 15.14% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Axa's SWAV Position: Q2 2024 in Review

Axa sold out of Shockwave Medical, Inc. Common Stock (SWAV) in Q2 2024, closing a stake of 142,510 shares — an estimated $46.4M sold.

Axa first reported a position in SWAV in Q1 2020 and held it in 13 quarters. The position peaked at $46.4M in Q1 2024. 7 funds tracked by Wall St. Rank hold SWAV as of Q2 2024.

  • Axa reported no remaining Shockwave Medical, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
  • Axa sold 142,510 Shockwave Medical, Inc. Common Stock shares in Q2 2024, an estimated $46.4M.
  • Axa first reported a position in Shockwave Medical, Inc. Common Stock in Q1 2020 and held it in 13 quarters.
  • Axa's Shockwave Medical, Inc. Common Stock position peaked at $46.4M in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q2 2024.

Based on Axa's 13F filing for Q2 2024, filed 14 Aug 2024.